CRA provided testimony on behalf of plaintiff in litigation regarding a health plan’s use of MFN clauses with hospitals. CRA identified several mechanisms by which the MFN clauses were likely to reduce competition in this matter and demonstrated that they had historically harmed competitors. CRA also analyzed whether this harm to competition was offset by the procompetitive effects of MFN clauses.
Former DOJ economist Goldstein moves to Charles River Associates
FTCWatch recently conducted an in-depth interview with Vice President Nate Goldstein, exploring his transition from a distinguished 23-year tenure at the...